Stockscreener 앱 받기
6.2616
1.15%
0.0316
전일 마감가:
$6.23
열려 있는:
$6.28
하루 거래량:
338.00K
Relative Volume:
0.33
시가총액:
$376.45M
수익:
$217.78M
순이익/손실:
$-239.55M
주가수익비율:
-1.5464
EPS:
-4.0492
순현금흐름:
$-127.30M
1주 성능:
+2.96%
1개월 성능:
+4.50%
6개월 성능:
-26.21%
1년 성능:
+28.86%
1일 변동 폭
$6.15
$6.31
1주일 범위
$5.955
$6.34
52주 변동 폭
$4.14
$9.94
Vanda Pharmaceuticals Inc Stock (VNDA) Company Profile
명칭
Vanda Pharmaceuticals Inc
전화
202-734-3400
주소
2200 PENNSYLVANIA AVE NW, WASHINGTON
Compare VNDA vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
VNDA
Vanda Pharmaceuticals Inc
|
6.26 | 373.44M | 217.78M | -239.55M | -127.30M | -4.0492 |
VRTX
Vertex Pharmaceuticals Inc
|
525.12 | 134.02B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
673.41 | 68.59B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
924.88 | 58.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
319.24 | 41.76B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
192.23 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
Vanda Pharmaceuticals Inc Stock (VNDA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-05 | 개시 | Truist | Buy |
| 2025-11-05 | 개시 | B. Riley Securities | Buy |
| 2024-10-31 | 개시 | H.C. Wainwright | Buy |
| 2024-07-11 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-02-25 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-05-12 | 개시 | BofA Securities | Buy |
| 2021-01-14 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-10-29 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-06-09 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-03-16 | 다운그레이드 | Oppenheimer | Perform → Underperform |
| 2020-03-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-11-07 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-08-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-07-25 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-12-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2018-12-04 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2018-12-04 | 재확인 | Jefferies | Buy |
| 2018-11-08 | 재개 | Jefferies | Buy |
| 2018-09-21 | 재개 | Oppenheimer | Outperform |
| 2018-05-23 | 개시 | Citigroup | Buy |
| 2018-01-19 | 개시 | Seaport Global Securities | Buy |
| 2017-09-14 | 재확인 | Piper Jaffray | Overweight |
| 2017-06-27 | 재개 | Piper Jaffray | Overweight |
| 2017-05-26 | 개시 | H.C. Wainwright | Buy |
| 2017-04-12 | 개시 | Oppenheimer | Outperform |
| 2016-11-09 | 개시 | Aegis Capital | Buy |
| 2016-10-06 | 재개 | Jefferies | Buy |
모두보기
Vanda Pharmaceuticals Inc 주식(VNDA)의 최신 뉴스
VNDA Stock Soars 40% Overnight After Bysanti Approval: What’s The Next Catalyst And How Much Upside Remains? - Stocktwits
Vanda Pharma Stock Rises Pre-Market After FDA Accepts Imsidolimab Filing For Rare Skin Disorder - Stocktwits
VNDA Stock Rises After Hours On Commercial Launch Of Motion Sickness Drug - Stocktwits
Why Did Vanda Pharmaceuticals Stock Slide 7% Pre-Market Today? - Stocktwits
VNDAVanda Pharmaceuticals Inc Volatility & Greeks - Finviz
McDermott Represents Vanda Pharmaceuticals Inc. on Acquisition of PONVORY® - McDermott Will & Schulte
Here’s Why H.C. Wainwright Remains a Buy on Vanda Pharmaceuticals (VNDA) - Yahoo Finance
Vanda Pharmaceuticals | 3: Initial statement of beneficial ownership of securities- McGuire Daniel Patrick - Moomoo
Vanda Pharmaceuticals Inc.(NasdaqGM:VNDA) dropped from Russell 2000 Defensive Index - marketscreener.com
Vanda Now Looks To Public Hearing For Hetlioz In Jet Lag Disorder After Multiple FDA Rejections - Stocktwits
Vanda Stock Draws Heavy Buzz Ahead Of FDA Verdict On Bysanti For Bipolar, Schizophrenia - Stocktwits
Vanda Pharmaceuticals Inc.(NasdaqGM:VNDA) dropped from Russell 2000 Value-Defensive Index - marketscreener.com
Vanda Pharmaceuticals Mallorca Women's Championships presented by Ecotrans Group 2026 Past Winners - WTA Tennis
Vanda Pharmaceuticals Mallorca Women's Championships presented by Ecotrans Group - WTA Tennis
Watch Vit Kopriva vs Ignacio Buse - tod.tv
Price to book forward of Vanda Pharmaceuticals Inc. – NASDAQ:VNDA - TradingView
Enterprise value to EBITDA forward of Vanda Pharmaceuticals Inc. – NASDAQ:VNDA - TradingView
Enterprise value to EBITDA forward of Vanda Pharmaceuticals Inc. – FWB:VM4 - TradingView
Price to earnings forward of Vanda Pharmaceuticals Inc. – NASDAQ:VNDA - TradingView
Enterprise value to EBITDA forward of Vanda Pharmaceuticals Inc. – LSX:A0JJT3 - TradingView
Enterprise value to EBIT forward of Vanda Pharmaceuticals Inc. – FWB:VM4 - TradingView
Price to earnings forward of Vanda Pharmaceuticals Inc. – FWB:VM4 - TradingView
Enterprise value to revenue forward of Vanda Pharmaceuticals Inc. – NASDAQ:VNDA - TradingView
Net current asset value per share of Vanda Pharmaceuticals Inc. – LSX:A0JJT3 - TradingView
Enterprise value to revenue forward of Vanda Pharmaceuticals Inc. – LSX:A0JJT3 - TradingView
Gastroparesis Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | CinDome Pharma, Inc., Evoke Pharma, Vanda Pharma, Ironwood Pharma, Takeda - Barchart.com
Athletics announces jersey patch partnership with biopharmaceutical company - The GW Hatchet
Vanda Pharmaceuticals Inc. Actuals & Estimates (NASDAQ:VNDA) - TradingView
VNDA Forecast — Price Target — Prediction for 2027 - TradingView
VNDA Stock Rallies After-Hours As FDA Approves Schizophrenia, Bipolar Disorder Drug - Stocktwits
Vanda Pharmaceuticals (VNDA) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Vanda Pharmaceuticals Inc (VNDA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Vanda Pharmaceuticals Inc (VNDA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Vanda Pharmaceuticals Inc (VNDA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
GW Athletics Names Vanda Pharmaceuticals First Official Jersey Patch Partner - George Washington University Athletics
Watch VANDA Pharmaceuticals Berlin Tennis Open (Quarterfinals) | Disney+ - Disney Plus
Licensable picture: VANDA Pharmaceuticals Berlin Tennis Open 2026 - reutersconnect.com
VNDA|Vanda Pharmaceuticals Inc|Price:6.000|Chg%:0.20 - TradingKey
Vanda Pharmaceuticals Inc (VNDA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Watch VANDA Pharmaceuticals Berlin Tennis Open / Court 1 (Doubles Quarterfinals) | Disney+ - Disney Plus
Vanda Pharmaceuticals Inc (VNDA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Vanda Pharmaceuticals Inc (VNDA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Vanda Pharmaceuticals Inc (VNDA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vanda Pharmaceuticals Inc (VNDA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
VANDA Pharmaceuticals Berlin Tennis Open 2026 - reutersconnect.com
Watch VANDA Pharmaceuticals Berlin Tennis Open (First Round) | Disney+ - Disney Plus
Watch VANDA Pharmaceuticals Berlin Tennis Open / Court 1 | Disney+ - Disney Plus
CEO’s Significant Stock Sale Raises Concerns for Vanda Pharmaceuticals - timothysykes.com
Vanda Pharmaceuticals Faces New Market Challenges Amid Share Sale and Regulatory Roadblocks - timothysykes.com
Watch VANDA Pharmaceuticals Berlin Tennis Open / Steffi Graf Stadion | Disney+ - Disney Plus
Vanda Pharmaceuticals Inc (VNDA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Vanda Pharmaceuticals Inc 주식 (VNDA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Moran Kevin Patrick | SVP, CFO & Treasurer |
Mar 02 '26 |
Sale |
8.27 |
42,442 |
350,821 |
411,380 |
| Wijkstrom Joakim | SVP, Chief Marketing Officer |
Mar 02 '26 |
Sale |
8.27 |
30,800 |
254,590 |
333,469 |
| Polymeropoulos Mihael Hristos | President and CEO |
Mar 02 '26 |
Sale |
8.17 |
156,235 |
1,276,971 |
2,704,496 |
| Birznieks Gunther | SVP, Business Development |
Mar 02 '26 |
Sale |
8.27 |
42,431 |
350,730 |
494,197 |
1.83%
3.59%
자본화:
|
볼륨(24시간):